SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GENZYME - THE KING OF THE BIOTECHS
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
410 21 0 GENZ
Emcee:  ajcmr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60 Harold...Please expand as to what is in the pipeline...The attention to whetherLarry Liebman-12/28/1996
59 Michael, the current decline of this stock is probably due to the general pessiMichael Yang-12/28/1996
58 Yeadon, I think Genzyme is cheap because it is a Biotech company with potentialHarold Engstrom-12/26/1996
57 Yeadon, I stated what analyst estimates are, I beleive their estimates to be toMichael H. Dragon-12/25/1996
56 Why do you think GENZ is cheap? If they earn $1.10 this year and $1.20 next yeYeadon-12/25/1996
55 Mike, Stone said that he expects that the sale of Seprafilm should take off inMichael Yang-12/24/1996
54 Harold,I heard it on CNBC,something Joe Kernan said. I couldn,t verify it throuMichael H. Dragon-12/24/1996
53 Michael, what do you mean by "companies guidance to analyst"? Do youHarold Engstrom-12/24/1996
52 How bad is it? Enough to bring GENZ back to 20.5?M. LaMancha-12/24/1996
51 I guess we got our answer earlier than I suspected.Apparently new product launcMichael H. Dragon-12/23/1996
50 Biotechs tradionally are strong this time of year,the case that FDA approves neMichael H. Dragon-12/21/1996
49 Yeah, this must be a good sign. They've confidence in it on the long term. Dirk Boodts-12/21/1996
48 Is it a sign of confidence? Dow Jones News Service ~ December 18, 1996 ~ 1:01 Charles D Dodai-12/19/1996
47 Don't know the warrant conditions. Maybe you know if it is favorable to conDirk Boodts-12/19/1996
46 And if the investors don't want them worthless, it looks like NASDAQ does. Mike Mee-12/18/1996
45 Roy, From previous two trading days, I saw a good support around 23 1/2. IMO, Charles D Dodai-12/17/1996
44 Charles, "Look like the investors want the Dec 25 call options to be wortRoy Snodgrass-12/17/1996
43 Look like the investors want the Dec 25 call options to be worthless. I hope wCharles D Dodai-12/17/1996
42 Tuesday December 17 2:37 PM EDT Genzyme Announces Cardiovascular Gene TherapyRoy Snodgrass-12/17/1996
41 Does anyone have any specifics about whether Seprafilm, the company's bioreM. LaMancha-12/16/1996
40 I base this on a report by CS First Boston, but it is still speculation of couUtahVC-12/16/1996
39 Do you have any basis for the $40 estimate, or is that just wishful thinking?Stephen Blumenthal-12/15/1996
38 This is tremendously undervalued. The should trade into the 40's in 6 monthUtahVC-12/13/1996
37 FRAMINGHAM, Mass., Dec. 9 /PRNewswire/ -- Genzyme Transgenics Corp. (Nasdaq: GHarold Engstrom-12/11/1996
36 IMHO = In My Humble Opinion...I know how you feel, I had and still do have a haMike Mee-12/8/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News